Everolimus although off label is being prescribed for patients with SEGA, epilepsy, Renal AMLs and Lymphangioleiomyomatosis (LAM), and topical mTOR inhibitor is being used for facial angiofibroma. This evidence concerns the gene MTOR and epilepsy.